PH16275A - 3-o-(b-d-glucuronopyranosyl)soyasapogenol b - Google Patents

3-o-(b-d-glucuronopyranosyl)soyasapogenol b

Info

Publication number
PH16275A
PH16275A PH22339A PH22339A PH16275A PH 16275 A PH16275 A PH 16275A PH 22339 A PH22339 A PH 22339A PH 22339 A PH22339 A PH 22339A PH 16275 A PH16275 A PH 16275A
Authority
PH
Philippines
Prior art keywords
glucuronopyranosyl
soyasapogenol
Prior art date
Application number
PH22339A
Other languages
English (en)
Inventor
Shinohara Masanao
Makano Yoshimasa
Izawa Taketoshi
Kaise Hirotsugu
Miyazaki Wasei
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PH16275A publication Critical patent/PH16275A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
PH22339A 1978-03-31 1979-03-30 3-o-(b-d-glucuronopyranosyl)soyasapogenol b PH16275A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53038536A JPS5822120B2 (ja) 1978-03-31 1978-03-31 ３−０−（β−Ｄ−グルクロノピラノシル）−ソ−ヤサポゲノ−ルＢ

Publications (1)

Publication Number Publication Date
PH16275A true PH16275A (en) 1983-08-26

Family

ID=12527996

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22339A PH16275A (en) 1978-03-31 1979-03-30 3-o-(b-d-glucuronopyranosyl)soyasapogenol b

Country Status (23)

Country Link
US (1) US4217345A (pt)
JP (1) JPS5822120B2 (pt)
AR (1) AR227624A1 (pt)
AT (1) AT369426B (pt)
AU (1) AU527201B2 (pt)
BE (2) BE875106A (pt)
CA (1) CA1128498A (pt)
CH (1) CH640868A5 (pt)
DE (1) DE2911353A1 (pt)
DK (1) DK162102C (pt)
ES (2) ES478874A1 (pt)
FI (1) FI67559C (pt)
FR (1) FR2421179A1 (pt)
GB (1) GB2020290B (pt)
IT (1) IT1126812B (pt)
MX (1) MX6305E (pt)
NL (1) NL7902449A (pt)
NO (1) NO154584C (pt)
PH (1) PH16275A (pt)
PT (1) PT69423A (pt)
SE (1) SE434269B (pt)
SU (2) SU1074408A3 (pt)
ZA (1) ZA791061B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528415B2 (en) * 1978-03-31 1983-04-28 Otsuka Pharmaceutical Co., Ltd. Anticomplementary agents
DE3040246C2 (de) * 1979-10-29 1985-01-10 Osaka Chemical Laboratory Co., Ltd., Osaka Sojasaponine A↓1↓ und A↓2↓ und ihre Verwendung
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
US6784159B2 (en) * 2000-09-29 2004-08-31 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture Triterpene saponins from soybeans for treating kidney disease
EP1422509A1 (en) * 2002-11-01 2004-05-26 Streck Laboratories, Inc. Lysing Reagent and Method of Lysing Red Blood Cells for Hematology
CA2539061A1 (en) * 2003-09-22 2005-03-31 Biovation Gmbh & Co. Kg Use of an antagonist of il-6 for treating il-6-mediated diseases
US20070141121A1 (en) * 2005-12-20 2007-06-21 Calton Gary J Method of treating kidney disease
EP2727586A4 (en) * 2011-06-28 2014-11-26 J Oil Mills Inc SOYASAPOGENOL COMPOSITION
CN106589043B (zh) * 2015-10-16 2019-02-26 复旦大学 芳基取代丙烯酰基三萜类化合物在制备抗补体药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377001A (en) * 1976-11-16 1978-07-08 Otsuka Pharmaceut Co Ltd New material and its preparation
JPS5399314A (en) * 1977-02-04 1978-08-30 Otsuka Pharmaceut Co Ltd Therapeutic agent for nephritis
AU528415B2 (en) * 1978-03-31 1983-04-28 Otsuka Pharmaceutical Co., Ltd. Anticomplementary agents

Also Published As

Publication number Publication date
ZA791061B (en) 1980-03-26
ES487982A0 (es) 1981-01-16
IT1126812B (it) 1986-05-21
ATA236079A (de) 1982-05-15
GB2020290B (en) 1982-10-27
FR2421179B1 (pt) 1983-03-18
IT7948551A0 (it) 1979-03-30
DK162102B (da) 1991-09-16
NL7902449A (nl) 1979-10-02
SE7902866L (sv) 1979-10-16
ES8102148A1 (es) 1981-01-16
JPS54130551A (en) 1979-10-09
SU1190989A3 (ru) 1985-11-07
DK126679A (da) 1979-10-01
NO790994L (no) 1979-10-02
AR227624A1 (es) 1982-11-30
CH640868A5 (de) 1984-01-31
FI67559C (fi) 1985-04-10
BE875105A (fr) 1979-09-26
AT369426B (de) 1982-12-27
BE875106A (fr) 1979-09-26
DK162102C (da) 1992-02-24
SU1074408A3 (ru) 1984-02-15
NO154584B (no) 1986-07-28
AU4499579A (en) 1979-10-04
NO154584C (no) 1986-11-05
FR2421179A1 (fr) 1979-10-26
CA1128498A (en) 1982-07-27
DE2911353A1 (de) 1979-10-11
DE2911353C2 (pt) 1987-10-29
GB2020290A (en) 1979-11-14
PT69423A (en) 1979-04-01
FI791011A (fi) 1979-10-01
AU527201B2 (en) 1983-02-24
ES478874A1 (es) 1980-10-01
MX6305E (es) 1985-03-29
FI67559B (fi) 1984-12-31
JPS5822120B2 (ja) 1983-05-06
US4217345A (en) 1980-08-12
SE434269B (sv) 1984-07-16

Similar Documents

Publication Publication Date Title
GB2027024B (en) Doxorubicin derivatives
JPS54163511A (en) Aminosugar derivative
JPS54146824A (en) Multidirectional structure
ZA796170B (en) Macromonomers
PH16275A (en) 3-o-(b-d-glucuronopyranosyl)soyasapogenol b
GB2012152B (en) Subsoiler
GB2021571B (en) Anthracycline glycosides
GB2027017B (en) 2-aminooctahydroindolo (i8o-a)quinolizines
JPS54123400A (en) Seallup implement
GB2032420B (en) Daunorubicin derivatives
GB2021680B (en) Latch-and-keeper mechanisms
JPS5563039A (en) Differential mechanism
GB2051096B (en) Macromonomers
GB2034707B (en) anthracycline glycosides
GB2021572B (en) Anthracycline glycosides
ZA794011B (en) Dietetic agent
GB2073304B (en) Latches
JPS54130301A (en) Subsoiler
JPS5534223A (en) Polypyrrolidoneeiodine complex
JPS5515771A (en) Subsoiler
JPS54160030A (en) Subsoiler
JPS5548301A (en) Subsoiler
PH13052A (en) Erythromycin therapy
IE780882L (en) Anthracyclones and anthracycline glycosides
IE781376L (en) Daunorubicin derivatives